Randomised, phase III trial of epoetin-β to treat chemotherapy-induced anaemia according to the EU regulation

Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis

(2009) M. Tonelli et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Weekly Administration of Epoetin Beta for Chemotherapy-induced Anemia in Cancer Patients: Results of a Multicenter, Phase III, Randomized, Double-blind, Placebo-controlled Study

(2009) Masahiro Tsuboi et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Department of Error

(2009)   LANCET

Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial

(2009) Noriyuki Katsumata et al.   LANCET

Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials

(2009) Julia Bohlius et al.   LANCET

Examining the Involvement of Erythropoiesis-Stimulating Agents in Tumor Proliferation (Erythropoietin Receptors, Receptor Binding, Signal Transduction), Angiogenesis, and Venous Thromboembolic Events

(2009) J. Fandrey et al.   ONCOLOGIST

Effect of treatment with epoetin-β on survival, tumour progression and thromboembolic events in patients with cancer: an updated meta-analysis of 12 randomised controlled studies including 2301 patients

(2008) M Aapro et al.   BRITISH JOURNAL OF CANCER

Continuing Reassessment of the Risks of Erythropoiesis-Stimulating Agents in Patients with Cancer

(2008) V. Juneja et al.   CLINICAL CANCER RESEARCH

Venous Thromboembolism and Mortality Associated With Recombinant Erythropoietin and Darbepoetin Administration for the Treatment of Cancer-Associated Anemia

(2008) Charles L. Bennett   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Weekly Epoetin Beta Maintains Haemoglobin Levels and Improves Quality of Life in Patients with Non-Myeloid Malignancies Receiving Chemotherapy

(2008) Y. Suzuki et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Effect of Once-Weekly Epoetin Beta on Survival in Patients With Metastatic Breast Cancer Receiving Anthracycline- and/or Taxane-Based Chemotherapy: Results of the Breast Cancer—Anemia and the Value of Erythropoietin (BRAVE) Study

(2008) Matti Aapro et al.   JOURNAL OF CLINICAL ONCOLOGY

Darbepoetin Alfa for the Treatment of Anemia in Patients With Active Cancer Not Receiving Chemotherapy or Radiotherapy: Results of a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

(2008) Robert E. Smith et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer

(2007) Gillian Thomas et al.   GYNECOLOGIC ONCOLOGY